$CRISPR Therapeutics (CRSP.US)$
Most of Wallstreet and retail investors don't understand Crispr and most see it as a very risky stock to invest in but once it begins rolling out its cures and making obscene amounts of cash..Along with license agreements to other companies Crispr Theraputics share price will rise significantly. ...
Most of Wallstreet and retail investors don't understand Crispr and most see it as a very risky stock to invest in but once it begins rolling out its cures and making obscene amounts of cash..Along with license agreements to other companies Crispr Theraputics share price will rise significantly. ...
5
$Tesla (TSLA.US)$
analysts will keep raising price targets with the share price and chance it up. some analysts havn't got a clue what they are doing and just hope for the best but still have a job when they get it significantly wrong. Other analysts just copy each others homework.
Is there any professional a...
analysts will keep raising price targets with the share price and chance it up. some analysts havn't got a clue what they are doing and just hope for the best but still have a job when they get it significantly wrong. Other analysts just copy each others homework.
Is there any professional a...
6
TechTrek Invest
commented on
$Tesla (TSLA.US)$ when is a good time to short? Lolx
1
7
TechTrek Invest
voted
Happy Monday, September 23, traders. The market was slowly rising, mostly flat Monday as investors digested all-time high indexes and a bit of tech stock pullback. FOMC rate cuts are feeling priced in, my name is Kevin Travers, and here are stonks and stories mooving on Wall Street today.
$Constellation Energy (CEG.US)$ climbed 6% at one point Monday morning, after analysts at Morgan Stanley raised their price target fr...
$Constellation Energy (CEG.US)$ climbed 6% at one point Monday morning, after analysts at Morgan Stanley raised their price target fr...
27
7
TechTrek Invest
commented on
$Ginkgo Bioworks (DNA.US)$ … Don’t buy.!!!!
3
TechTrek Invest
liked
$Ginkgo Bioworks (DNA.US)$
Ginkgo Bioworks Launches New Protein LLM and Model API Built on Google Cloud Technology
Ginkgo Bioworks (NYSE: DNA) has launched two new offerings to accelerate drug development, building on its partnership with Google Cloud. The first is a protein large language model (LLM)built with Google Cloud Consulting, designed to give researchers and companies insights from Ginkgo's private data. The second is a model API, allowing direct access to biological AI models.
Th...
Ginkgo Bioworks Launches New Protein LLM and Model API Built on Google Cloud Technology
Ginkgo Bioworks (NYSE: DNA) has launched two new offerings to accelerate drug development, building on its partnership with Google Cloud. The first is a protein large language model (LLM)built with Google Cloud Consulting, designed to give researchers and companies insights from Ginkgo's private data. The second is a model API, allowing direct access to biological AI models.
Th...
1
TechTrek Invest
liked
1
1